| 1 | Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA) | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 54 |
| 2 | Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 52 |
| 3 | Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2021 | 48 |
| 4 | A modern concept of antihypoxic and antioxidant effects of mexidol | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 42 |
| 5 | Cortexin. Molecular mechanisms and targets of neuroprotective activity | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 39 |
| 6 | Problems of mental health in the situation of COVID-19 pandemic | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 36 |
| 7 | Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO) | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2021 | 34 |
| 8 | Ischemic stroke in young adults | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 31 |
| 9 | Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2019 | 31 |
| 10 | Cardiovascular mortality in the Russian Federation and possible mechanisms of its changes | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 30 |
| 11 | Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 30 |
| 12 | The development of a pharmacologically active low-molecular mimetic of the nerve growth factor | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 28 |
| 13 | Modern trends in epidemiology of dementia and management of patients with cognitive impairment | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 27 |
| 14 | Results of implementation of a 'Complex of measures to improve medical care for patients with stroke in the Russian Federation' | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 27 |
| 15 | Endothelial dysfunction in COVID- 19 and cognitive impairment | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2021 | 25 |
| 16 | The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer’s disease | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 25 |
| 17 | Diagnosis and treatment of migraine: Recommendations of the Russian experts | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 25 |
| 18 | The optimization of management of chronic daily headache patients | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 25 |
| 19 | Outcomes of surgical treatment of patients with pharmacoresistant epilepsy | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2016 | 25 |
| 20 | Clinical guidelines "Migraine" | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2022 | 25 |
| 21 | Results of a randomized double blind parallel study on the efficacy and safety of tolpersione in patients with acute nonspecific low back pain | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 24 |
| 22 | Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 24 |
| 23 | Direct and indirect neurological manifestations of COVID-19 | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 24 |
| 24 | Therapy of moderate cognitive impairment in the early recovery period of ischemic stroke | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2021 | 22 |
| 25 | Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 22 |
| 26 | Modern pathogenetic aspects of development of cerebral chronic ischemia | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 22 |
| 27 | Parkinson's disease and glutamate excitotoxicity | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 21 |
| 28 | The third case report a patient with primary aldosteronism, seizures, and neurologic abnormalities (PASNA) syndrome de novo variant mutations in the CACNA1D gene | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 21 |
| 29 | Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 20 |
| 30 | The efficacy of the exoskeleton ExoAtlet to restore walking in patients with multiple sclerosis | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 20 |
| 31 | A comparative chemoreactome analysis of mexidol | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 20 |
| 32 | Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study) | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 20 |
| 33 | A systematic review of using myorelaxants in treatment of low back pain | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 20 |
| 34 | Exercise for depression treatment. Physiological mechanisms | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2019 | 20 |
| 35 | Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2016 | 19 |
| 36 | Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 19 |
| 37 | Review of clinical guidelines for the treatment and prevention of ischemic stroke | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2019 | 19 |
| 38 | The effect of Mexidol on cerebral mitochondriogenesis at a young age and during aging | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 19 |
| 39 | Stress-induced disorders | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 19 |
| 40 | Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2022 | 19 |
| 41 | The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2015 | 18 |
| 42 | The prevalence of autism: genuine and imaginary | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2019 | 18 |
| 43 | SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 18 |
| 44 | Features of neurological manifestations of the COVID-19 in children and adults | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2020 | 18 |
| 45 | The system stress-limiting action of mexidol in chronic cerebral ischemia | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2016 | 17 |
| 46 | Gut human microbiota and multiple sclerosis | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 17 |
| 47 | Postoperative cerebral dysfunction | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 17 |
| 48 | Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2017 | 17 |
| 49 | The Russian version of Coma Recovery Scale-revised - a standardized method for assessment of patients with disorders of consciousness | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 17 |
| 50 | The efficacy of semax in the tretament of patients at different stages of ischemic stroke | Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova | 2018 | 17 |
